SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 27, 2004 (April 27, 2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
DELAWARE
|
001-15989 | 13-4022871 | ||
(State or other
|
(Commission File Number) | (I.R.S. Employer | ||
jurisdiction of
|
Identification No.) | |||
incorporation) |
||||
| 100 Painters Drive | ||||
| Chadds Ford, Pennsylvania | 19317 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| SLIDE PRESENTATION | ||||||||
Item 7. Financial Statements and Exhibits.
| (a) | Financial Statements of Business Acquired. |
Not applicable.
| (b) | Pro Forma Financial Information. |
Not applicable.
| (c) | Exhibits. |
| Exhibit Number |
Description |
|
99.1
|
Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated April 27, 2004 |
Item 9. Regulation FD Disclosure.
On April 27, 2004, the Registrant intends to make a slide presentation at the CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference in New York, New York, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. | ||||||
| (Registrant) | ||||||
| By: | /s/ CAROL A. AMMON | |||||
| Name: | Carol A. Ammon | |||||
| Title: | Chairman & Chief Executive Officer | |||||
Dated: April 27, 2004 |
||||||